Wübker Ansgar
Department of Economics, Institutional Economics and Health Systems Management, Witten/Herdecke University, Alfred-Herrhausen-Str. 50, 58448, Witten, Germany,
Eur J Health Econ. 2014 Jun;15(5):497-514. doi: 10.1007/s10198-013-0490-3. Epub 2013 Jun 7.
In this study I aim to explore the statistical causes of country differences in mammography screening among women aged 50-69 years in 13 European countries. I focus on the relative importance of individual (e.g. age, education, etc.) and institutional (e.g. public screening programmes) factors in explaining these differences.
I use individual level data from the first three waves (2004-2006-2009) of the SHARE as well as regional and country level data on institutional factors. The analytical approach is based on multilevel statistical models, which allow me to analyse the contribution of individual and institutional factors in explaining the variation in breast cancer screening across European countries.
I find that the standard deviation in screening rates across countries increases slightly from 19.5 to 20.8 per cent after controlling for individual factors. Observed individual factors such as age, education, health status, etc., do not significantly contribute to the explanation of cross-country differences. In contrast, after controlling for observed institutional factors such as the availability of an organised screening programme, the standard deviation drops from 20.86 to 12.92 per cent. These factors can statistically explain about 40 per cent of the between-country differences in screening rates. Moreover, I found that these institutional factors seem to prevent a woman from considering a mammogram "not necessary".
This analysis provides important insights about patient's attitudes and understanding of benefits of breast cancer prevention and highlights the importance of the availability of an organised screening programme for screening differences across European countries.
在本研究中,我旨在探究13个欧洲国家50至69岁女性乳腺钼靶筛查存在国家差异的统计原因。我关注个体因素(如年龄、教育程度等)和机构因素(如有组织的筛查项目)在解释这些差异方面的相对重要性。
我使用了来自SHARE前三轮(2004 - 2006 - 2009年)的个体层面数据以及关于机构因素的地区和国家层面数据。分析方法基于多层次统计模型,这使我能够分析个体和机构因素在解释欧洲国家乳腺癌筛查差异方面的作用。
我发现,在控制个体因素后,各国筛查率的标准差从19.5%略有上升至20.8%。观察到的个体因素,如年龄、教育程度、健康状况等,对解释国家间差异的贡献并不显著。相比之下,在控制了有组织的筛查项目的可及性等观察到的机构因素后,标准差从20.86%降至12.92%。这些因素在统计学上可以解释约40%的国家间筛查率差异。此外,我发现这些机构因素似乎能使女性不认为钼靶检查“没必要”。
该分析为患者对乳腺癌预防益处的态度和理解提供了重要见解,并凸显了有组织的筛查项目的可及性对于欧洲国家筛查差异的重要性。